PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, CA.\', \'Division of Infectious Diseases & Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA.\', \'Center for Computational Biology, College of Engineering, University of California, Berkeley, Berkeley, CA.\', \'COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.\', \'Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.\', \'Division of Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA.\', \'Department of Biostatistics, University of Florida, Gainesville, FL.\', \'WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, University of Hong Kong, Hong Kong, China.\', \'Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1097/EDE.0000000000001366
?:doi
?:hasPublicationType
?:journal
  • Epidemiology (Cambridge, Mass.)
is ?:pmid of
?:pmid
?:pmid
  • 34001753
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all